Finance Watch: Vertex Ventures, Chugai Each Raise New $200m VC Funds
Vesalius Raises €95m For Fourth Fund
Private Company Edition: Vertex Ventures (not Vertex Pharmaceuticals) closed its third fund, with $200m for life science and medical technologies, while Chugai’s $200m corporate VC fund will invest in drug discovery start-ups. Also, K36 closed a $70m series B round and Attovia launched with $60m.
